Nodular pulmonary amyloidosis with primary pulmonary MALT lymphoma masquerading as metastatic lung disease.
作者信息
Upadhaya Sunil, Baig Mohd, Towfiq Basim, Al Hadidi Samer
机构信息
Internal Medicine Department, Hurley Medical Center, One Hurley Plaza, Flint, MI, USA.
出版信息
J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):185-189. doi: 10.1080/20009666.2017.1343075. eCollection 2017 Jul.
Abstract
Nodular pulmonary amyloidosis is a very rare form of localized amyloidosis involving the lung, with very little known about its nature. It is usually associated with indolent B cell lymphoproliferative disorder and also connective tissue disorders. No definite treatment guideline exists. Many patients respond to chemotherapy with low risk of progression and a 'wait and watch' strategy is also considered a valid treatment option. In this report the authors present a case of nodular pulmonary amyloidosis with pulmonary mucosa associated lymphoid tissue (MALT) lymphoma that presented with features of metastatic malignant disease and after definitive diagnosis decided not to undergo treatment.
摘要
相似文献
1
Nodular pulmonary amyloidosis with primary pulmonary MALT lymphoma masquerading as metastatic lung disease.
J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):185-189. doi: 10.1080/20009666.2017.1343075. eCollection 2017 Jul.
2
Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
Am J Surg Pathol. 2013 Mar;37(3):406-12. doi: 10.1097/PAS.0b013e318272fe19.
3
Nodular Pulmonary Amyloidosis Preceding Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Initially Suspected to Be Lung Cancer.
Tokai J Exp Clin Med. 2023 Sep 20;48(3):91-94.
4
Nodular pulmonary amyloidosis and obvious ossification due to primary pulmonary MALT lymphoma with extensive plasmacytic differentiation: Report of a rare case and review of the literature.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7482-7. eCollection 2015.
5
Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma.
Eur Respir J. 2007 Sep;30(3):589-92. doi: 10.1183/09031936.00136605.
6
Nodular pulmonary amyloidosis: a complex disease with malignancy association.
BMJ Case Rep. 2017 Oct 15;2017:bcr-2017-220428. doi: 10.1136/bcr-2017-220428.
7
[Pulmonary MALT lymphoma and paraneoplastic syndromes].
Rev Mal Respir. 2016 Nov;33(9):799-803. doi: 10.1016/j.rmr.2016.02.008. Epub 2016 May 4.
8
[Nodular amyloidoma associated with primary pulmonary Malt lymphoma].
Rev Mal Respir. 2008 Nov;25(9):1123-6. doi: 10.1016/s0761-8425(08)74983-0.
9
Lymphoproliferative Disorders of the Lung.
Respiration. 2017;94(2):157-175. doi: 10.1159/000477740. Epub 2017 Jun 14.
10
Primary Pulmonary Involvement in Mucosa-associated Lymphoid Tissue Lymphoma.
Cureus. 2019 Jul 9;11(7):e5110. doi: 10.7759/cureus.5110.
引用本文的文献
1
Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis.
Surg Case Rep. 2019 Jun 26;5(1):105. doi: 10.1186/s40792-019-0663-0.
本文引用的文献
1
Nodular pulmonary amyloidosis with spontaneous fatal blood aspiration.
Forensic Sci Int. 2016 May;262:e1-4. doi: 10.1016/j.forsciint.2016.03.017. Epub 2016 Mar 17.
2
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
Blood. 2016 Apr 28;127(17):2082-92. doi: 10.1182/blood-2015-12-624304. Epub 2016 Mar 17.
3
Nodular pulmonary amyloidosis and obvious ossification due to primary pulmonary MALT lymphoma with extensive plasmacytic differentiation: Report of a rare case and review of the literature.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7482-7. eCollection 2015.
4
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia.
Blood. 2015 Apr 9;125(15):2336-43. doi: 10.1182/blood-2014-08-595934. Epub 2015 Feb 18.
5
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Lancet Oncol. 2014 Nov;15(12):1311-8. doi: 10.1016/S1470-2045(14)70455-3. Epub 2014 Oct 15.
6
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.
7
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2013 Oct;24 Suppl 6:vi144-8. doi: 10.1093/annonc/mdt343.
8
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.
J Clin Oncol. 2013 Feb 10;31(5):565-72. doi: 10.1200/JCO.2011.40.6272. Epub 2013 Jan 7.
9
Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
Am J Surg Pathol. 2013 Mar;37(3):406-12. doi: 10.1097/PAS.0b013e318272fe19.
10
A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).
Haematologica. 2013 Mar;98(3):353-6. doi: 10.3324/haematol.2012.065995. Epub 2012 Aug 16.
Zotero 插件